Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Asthma pharmacogenomics.

Gregory A Hawkins1, Scott T Weiss, Eugene R Bleecker

  • 1Center for Human Genomics, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA. ghawkins@wfubmc.edu

Immunology and Allergy Clinics of North America
|November 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A cross-sectional study of oxidative stress pathway genotypes and their interactions with environmental pollutant levels identifies associations with gene expression and lung function.

EBioMedicine·2026
Same author

Exacerbations and Decreased Lung Function Predict Nebulizer Use and Uptake in COPD and Tobacco Exposed Persons With Preserved Spirometry

Chronic obstructive pulmonary diseases (Miami, Fla.)·2026
Same author

PrecISE-a biomarker-stratified adaptive trial of 5 interventions in severe asthma: Final protocol and the baseline cohort.

The Journal of allergy and clinical immunology·2026
Same author

A Quantitative Lung Mucin Score to Identify Chronic Bronchitis.

NEJM evidence·2026
Same author

Benralizumab: Bringing winds of change to eosinophil-associated diseases.

The World Allergy Organization journal·2025
Same author

Epigenomic study of the lower airway reveals COPD-associated methylation patterns and potential microbiota links.

BMJ open respiratory research·2025
Same journal

Anaphylaxis: State-of-the-Art.

Immunology and allergy clinics of North America·2026
Same journal

Upending Impending Doom.

Immunology and allergy clinics of North America·2026
Same journal

Mast Cell Activation Syndrome and Mimickers.

Immunology and allergy clinics of North America·2026
Same journal

Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same journal

Emerging Therapies for Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same journal

Novel Epinephrine Delivery Devices.

Immunology and allergy clinics of North America·2026
See all related articles

Future asthma treatments may use genetic tests for personalized medication, reducing side effects. However, widespread pharmacogenomics adoption depends on cost, usability, and result interpretation, not just test availability.

Area of Science:

  • Pharmacogenomics
  • Asthma Therapeutics
  • Genetic Testing

Background:

  • Personalized medicine is advancing asthma treatment.
  • Genetic information can guide medication selection.
  • Reducing adverse drug reactions is a key goal.

Purpose of the Study:

  • To explore the future application of pharmacogenomics in asthma therapy.
  • To identify factors influencing the adoption of pharmacogenomic testing for asthma.

Main Methods:

  • Review of current trends in pharmacogenomics and asthma treatment.
  • Analysis of potential barriers and facilitators for clinical implementation.

Main Results:

  • Genetic testing is expected to precede asthma medication prescription.

Related Experiment Videos

  • Not all genetic factors influencing drug response need to be known for initial pharmacogenomic application.
  • Test availability alone may not drive adoption.

    • Conclusions:

    • Pharmacogenomics holds promise for optimizing asthma pharmacotherapy.
    • Widespread use of pharmacogenomics in asthma care hinges on practical considerations like cost and interpretability.
    • Ease of use and affordability are critical for integrating genetic tests into routine asthma management.